“Attention Shareholders: Don’t Miss Out on Potential Gains – Pomerantz Law Firm Reminds You to Take Action!”

Cassava Sciences, Inc. Faces Class Action Lawsuit NEW YORK, NY / ACCESS Newswire / February 1, 2025 Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ:SAVA). Investors who have shares in Cassava Sciences, Inc. (NASDAQ:SAVA) have recently been hit with a class action lawsuit….

Read More

“Important Shareholder Notice: Pomerantz Law Firm Urges Shareholders with Losses to Take Action”

Class Action Lawsuit Filed Against Revance Therapeutics, Inc. Legal Troubles for Revance NEW YORK CITY, NY / ACCESS Newswire / February 1, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ:RVNC) and certain officers. The class action, filed in the United States…

Read More

“Attention Shareholders: Pomerantz Law Firm Reminds Investors with LO Stock to Take Action”

Class Action Lawsuit Filed Against Kaspi.kz What Investors Need to Know On February 1, 2025, Pomerantz LLP announced that a class action lawsuit has been filed against Joint Stock Company Kaspi.kz (NASDAQ:KSPI). Investors who have purchased shares of Kaspi.kz are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. The Allegations…

Read More

“Attention Shareholders: Pomerantz Law Firm Sends Reminder to Those with LO Stock”

Class Action Lawsuit Filed Against Applied Therapeutics, Inc. New York, NY / ACCESS Newswire / February 1, 2025 / Pomerantz LLP has announced that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:APLT). Investors who have been affected are advised to contact Danielle Peyton at [email protected] or…

Read More